Allelix (now NPS Pharmaceuticals) develops novel pharmaceuticals for neurological and CNS disorders Jan. 13, 2000
Knoll compounds with nanomolar affinity for 5-HT, dopamine and adrenergic receptor subtypes Jan. 13, 2000
16-HETE analogues useful for treating conditions associated with neutrophil adhesion/aggregation Jan. 11, 2000
Sedative/hypnotic neuroactive steroids from CoCensys successfully pass preclinical screening Jan. 10, 2000
RSS